extract: 2026-03-10-uk-lords-inquiry-nhs-ai-personalised-medicine

Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70>

inbox/queue/2026-03-10-uk-lords-inquiry-nhs-ai-personalised-medicine.md

@@ -7,9 +7,12 @@ date: 2026-03-10
 domain: health
 secondary_domains: []
 format: policy-document
-status: unprocessed
+status: enrichment
 priority: medium
 tags: [nhs, clinical-ai-safety, uk-policy, regulatory-pressure, personalised-medicine, innovation-adoption, belief-3, belief-5]
+processed_by: vida
+processed_date: 2026-03-24
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -56,3 +59,12 @@ The House of Lords Science and Technology Committee launched a new inquiry: **"I
 PRIMARY CONNECTION: Regulatory track from Session 11 + Belief 3 structural misalignment
 WHY ARCHIVED: New UK policy mechanism that could affect NHS AI governance in 2026-2027; inquiry framing (adoption blockage) is different from EU AI Act (safety requirements)
 EXTRACTION HINT: Watch for inquiry report (expected late 2026 or early 2027); the recommendations may create new NHS AI governance standards that bridge the commercial-research gap from the supply/procurement side
+
+
+## Key Facts
+- House of Lords Science and Technology Committee inquiry launched March 10, 2026
+- First evidence session featured Professor Sir Mark Caulfield from 100,000 Genomes Project
+- Written evidence deadline set for April 20, 2026
+- Inquiry ongoing through 2026 with report expected late 2026 or early 2027
+- Inquiry framing focuses on adoption gap between UK life sciences innovation and NHS deployment
+- Coverage in UK Parliament website, HTN Health Tech News, Precision Medicine Online, Pathology News